A NADPH Oxidase–Dependent Redox Signaling Pathway Mediates the Selective Radiosensitization Effect of Parthenolide in Prostate Cancer Cells

Abstract

Cancer cells are usually under higher oxidative stress compared with normal cells. We hypothesize that introducing additional reactive oxygen species (ROS) insults or suppressing antioxidant capacity may selectively enhance cancer cell killing by oxidative stress-generating agents through stress overload or stress sensitization, whereas normal cells may be able to maintain redox homeostasis under exogenous ROS by adaptive response. Here, we show that parthenolide, a sesquiterpene lactone, selectively exhibits a radiosensitization effect on prostate cancer PC3 cells but not on normal prostate epithelial PrEC cells. Parthenolide causes oxidative stress in PC3 cells but not in PrEC cells, as determined by the oxidation of the ROS-sensitive probe H 2 DCFDA and intracellular reduced thiol and disulfide levels. In PC3 but not PrEC cells, parthenolide activates NADPH oxidase, leading to a decrease in the level of reduced thioredoxin, activation of phosphoinositide 3-kinase/Akt, and consequent FOXO3a phosphorylation, which results in the downregulation of FOXO3a targets antioxidant enzyme manganese superoxide dismutase and catalase. Importantly, when combined with radiation, parthenolide further increases ROS levels in PC3 cells whereas it decreases radiation-induced oxidative stress in PrEC cells, possibly by increasing reduced glutathione levels. Together, the results show that parthenolide selectively activates NADPH oxidase and mediates intense oxidative stress in prostate cancer cells by both increasing ROS generation and decreasing antioxidant defense capacity. The results support the concept of exploiting the intrinsic differences in the redox status of cancer cells and normal cells as targets for selective cancer killing. Cancer Res; 70(7); 2880-90. ©2010 AACR.

Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction

“…Other studies have shown that tumor cells have lower level of GSH (40) and GSTp (41) than normal cells. Higher levels of GSH and GSTp have been associated with drug resistance to chemotherapy.…”

PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation

“…6,33 Inhibition of FOXO1/3 increases intracellular ROS through the regulation of antioxidant enzymes levels, such as MnSOD, sestrin, and catalase, and many experiments have shown that ROS have a critical role in determining life span and cellular senescence in mammalian cells. 5 In this study, ROS levels were elevated during IR-induced senescence, and the ROS scavenger NAC reverted IR-induced senescence phenotypes, including p53 activation, p21 induction, and SA-b-Gal activity.…”

RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation

“…However, the pathway of RIP3 mediated apoptosis has not been clearly elucidated. Furthermore, the influence of RIP3 on NF-κB, an inhibitor of apoptosis [22][23][24] , is controversial. In some studies, NF-κB appears to be induced by RIP3 overexpression [25,26] , but in other studies, RIP3 has no effect on its activation, but rather, acts by attenuating RIP1 and TNFR1-mediated NF-κB activation [27] .…”

“…PTL-induced apoptosis is also associated with increased ROS level in tumor cells because of the activation of NADPH oxidase and reduction of the cysteine group of the antioxidant, non-protein molecule glutathione [22,23] . ROS are ions or small molecules that include singlet oxygen molecules, free radicals and peroxides and are formed as byproducts of the normal cellular metabolism of oxygen [24] .…”